Baby Bleeds Spike After Shot Refusals

Newborn baby sleeping in a striped hat — Photo: Olga Max / Shutterstock

More U.S. babies are bleeding because more parents are skipping the newborn vitamin K shot, and the numbers are not small.

Story Snapshot

A study of 5.2 million births found higher six-month bleeding without vitamin K.
Any bleeding rose from 1.9% to 2.9% when parents declined the shot.
Intracranial bleeding risk more than doubled without vitamin K.
Refusal grew from 3.1% in 2017 to 6.8% in 2025.

What the new research shows in plain terms

Researchers examined 5.2 million U.S. infants and tracked bleeding in the first six months. Babies who did not receive intramuscular vitamin K had 288 bleeding events per 10,000 births, compared with 186 per 10,000 among those who did receive it. That is a clear difference. A companion report summarized that 2.9% of nonrecipients bled versus 1.9% of recipients, a 47% relative increase. The signal held across many sites and years. These are not fringe clinic data points.

Severe outcomes mattered most. The study found intracranial bleeding at 33.0 per 10,000 among nonrecipients and 13.2 per 10,000 among recipients. The adjusted relative risk was about 2.4, with a tight confidence range. Head bleeds can kill or leave lasting disability. This is why hospitals treat vitamin K as routine. One dose at birth helps the blood clot until the baby’s own stores build. That bridge can be the difference between a scare and a tragedy.

The refusal trend is real and growing

The share of babies leaving the hospital without a vitamin K shot rose from 3.1% in 2017 to 6.8% in 2025 in the same national dataset. Children’s Hospital of Philadelphia described that as more than doubling, and flagged it as a public health concern. Another analysis of over 11 million infants reported that while supplementation decreased, diagnoses of vitamin K deficiency and vitamin-K-deficiency bleeding rose during 2017 to 2025. Fewer shots. More bleeding diagnoses. The lines move in opposite directions.

Vitamin K prophylaxis is not new or experimental. The American Academy of Pediatrics has recommended a single intramuscular dose since 1961. The United States adopted the practice in the 1960s to prevent a known risk in newborns whose natural vitamin K levels start low. That history matters. The shot turned a rare but terrifying disease into something even rarer. As bleeding faded from view, the benefit became easy to doubt. The new data bring that benefit back into focus.

Risk explained the way parents actually weigh it

Most babies will not bleed either way. That is true. But the gap the studies report is not hand-waving. For any bleeding, the absolute difference is about one extra event per 100 babies when the shot is skipped. For head bleeds, the risk more than doubles without vitamin K. Parents choose every day to lower small risks that carry high stakes. We buckle a newborn into a car seat for the same reason. Low odds, huge downside, simple fix.

Some parents ask about oral drops. The new reports focus on the standard intramuscular shot. Prior evidence shows that oral regimens vary, depend on repeat dosing, and can fail if doses are missed. The shot is one dose, given once, with strong and durable protection. That is why hospitals prefer it. A brief caveat applies: the main study was observational and cannot prove causation for each single case, but its size and consistency make the link hard to dismiss.

What aligns with common sense and conservative values

This is a low-cost, one-time step that prevents high-cost, high-sorrow outcomes. Families carry the burden when a preventable head bleed happens. So do taxpayers, through emergency care and long-term support. A simple shot protects life, preserves parental peace of mind, and respects limited hospital resources. That is prudent stewardship. Parents deserve straight facts without scare tactics. The facts here are clear, numerate, and actionable, and they point to one choice that stacks the odds in a baby’s favor.